FDA Issues Notice in Recall of More Than 140,000 Bottles of Common Statin Medication

Several versions of generic atorvastatin calcium tablets are under recall, the agency says.

The logo of the U.S. Food and Drug Administration (FDA) is seen on a sign outside the agency's White Oak campus in Silver Spring, Maryland., on July 17, 2025. Issam Ahmed/AFP via Getty Images

The Food and Drug Administration (FDA) recently said that it issued a Class II classification notice to a recall of at least 140,000 bottles of the generic version of atorvastatin, a commonly used drug prescribed to treat cholesterol and heart issues.

In a notice issued on Oct. 10, the agency said that several versions of generic atorvastatin calcium tablets are under recall because of failed dissolution specifications, indicating the drug did not dissolve at the expected rate under FDA guidelines. This means that a patient may not be able to absorb the medication properly, according to the FDA.